Literature DB >> 15352162

Regulation of histone deacetylase activities.

Nilanjan Sengupta1, Edward Seto.   

Abstract

Histone deacetylases (HDACs) are enzymes that catalyze the removal of acetyl groups from lysine residues in both histone and non-histone proteins. They play a key role in the regulation of gene transcription and many other biological processes involving chromatin. Significantly, recent studies suggest that HDACs are critically involved in cell-cycle regulation, cell proliferation, differentiation, and in the development of human cancer. HDAC inhibitors currently are being exploited as potential anti-cancer agents. As expected for vital regulators of many cellular processes, the activities of HDACs are tightly controlled and precisely regulated by multiple mechanisms. The activities of most if not all HDACs are regulated by protein-protein interactions. In addition, many HDACs are regulated by post-translational modifications as well as by subcellular localization. Less studied, but perhaps equally important, is the regulation of some HDACs by control of expression, availability of cofactors, and by proteolytic processing. A complete understanding of how HDACs are regulated will contribute not only to our overall knowledge of chromatin structure and gene control, but will offer tremendous insight into approaches for developing therapeutic HDAC inhibitors with improved specificity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15352162     DOI: 10.1002/jcb.20179

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  130 in total

1.  Acetylation of core histones in response to HDAC inhibitors is diminished in mitotic HeLa cells.

Authors:  Jason S Patzlaff; Edith Terrenoire; Bryan M Turner; William C Earnshaw; James R Paulson
Journal:  Exp Cell Res       Date:  2010-05-07       Impact factor: 3.905

Review 2.  Protective effects and mechanisms of sirtuins in the nervous system.

Authors:  Feng Zhang; Suping Wang; Li Gan; Peter S Vosler; Yanqin Gao; Michael J Zigmond; Jun Chen
Journal:  Prog Neurobiol       Date:  2011-09-10       Impact factor: 11.685

3.  Metastasis-associated protein 3 (MTA3) regulates G2/M progression in proliferating mouse granulosa cells.

Authors:  Jakub Kwintkiewicz; Elizabeth Padilla-Banks; Wendy N Jefferson; Ilana M Jacobs; Paul A Wade; Carmen J Williams
Journal:  Biol Reprod       Date:  2012-03-08       Impact factor: 4.285

Review 4.  The role of histone acetylation in memory formation and cognitive impairments.

Authors:  Lucia Peixoto; Ted Abel
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

Review 5.  Epigenetic control of aging.

Authors:  Ursula Muñoz-Najar; John M Sedivy
Journal:  Antioxid Redox Signal       Date:  2010-11-22       Impact factor: 8.401

6.  Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis.

Authors:  Roel H Wilting; Eva Yanover; Marinus R Heideman; Heinz Jacobs; James Horner; Jaco van der Torre; Ronald A DePinho; Jan-Hermen Dannenberg
Journal:  EMBO J       Date:  2010-06-22       Impact factor: 11.598

7.  Coactivators and corepressors of NF-kappaB in IkappaB alpha gene promoter.

Authors:  Zhanguo Gao; Paul Chiao; Xia Zhang; Xiaohong Zhang; Mitchell A Lazar; Edward Seto; Howard A Young; Jianping Ye
Journal:  J Biol Chem       Date:  2005-04-04       Impact factor: 5.157

Review 8.  Class II histone deacetylases: from sequence to function, regulation, and clinical implication.

Authors:  Xiang-Jiao Yang; Serge Grégoire
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

9.  BIX01294 suppresses osteoclast differentiation on mouse macrophage-like Raw264.7 cells.

Authors:  Hiromasa Tsuda; Ning Zhao; Kenichi Imai; Kuniyasu Ochiai; Pishan Yang; Naoto Suzuki
Journal:  Bosn J Basic Med Sci       Date:  2013-11       Impact factor: 3.363

10.  Alternative Modes of Binding of Recombinant Human Histone Deacetylase 8 to Colloidal Gold Nanoparticles.

Authors:  Nitesh Sule; Raushan Singh; D K Srivastava
Journal:  J Biomed Nanotechnol       Date:  2008-12-01       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.